| __timestamp | BioCryst Pharmaceuticals, Inc. | Halozyme Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 13608000 | 75334000 |
| Thursday, January 1, 2015 | 48257000 | 135057000 |
| Friday, January 1, 2016 | 26353000 | 146691000 |
| Sunday, January 1, 2017 | 25186000 | 316613000 |
| Monday, January 1, 2018 | 20653000 | 151862000 |
| Tuesday, January 1, 2019 | 48835000 | 195992000 |
| Wednesday, January 1, 2020 | 17812000 | 267594000 |
| Friday, January 1, 2021 | 157170000 | 443310000 |
| Saturday, January 1, 2022 | 270827000 | 660116000 |
| Sunday, January 1, 2023 | 331412000 | 829253000 |
| Monday, January 1, 2024 | 1015324000 |
In pursuit of knowledge
In the dynamic world of biotechnology, revenue growth is a key indicator of a company's success and market position. Over the past decade, Halozyme Therapeutics, Inc. and BioCryst Pharmaceuticals, Inc. have shown distinct revenue trajectories. From 2014 to 2023, Halozyme's revenue surged by over 1,000%, reaching approximately $829 million in 2023. This impressive growth reflects the company's strategic advancements and market penetration. In contrast, BioCryst Pharmaceuticals experienced a more modest increase of around 2,300%, culminating in a revenue of about $331 million in 2023. This divergence highlights the varying strategies and market responses within the biotech sector. As these companies continue to innovate, their revenue trends offer valuable insights into the evolving landscape of biotechnology.
Comparing Revenue Performance: AbbVie Inc. or BioCryst Pharmaceuticals, Inc.?
Revenue Insights: AstraZeneca PLC and BioCryst Pharmaceuticals, Inc. Performance Compared
Breaking Down Revenue Trends: GSK plc vs BioCryst Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. vs Halozyme Therapeutics, Inc.: Examining Key Revenue Metrics
Comparing Revenue Performance: Viatris Inc. or BioCryst Pharmaceuticals, Inc.?
Annual Revenue Comparison: Jazz Pharmaceuticals plc vs Halozyme Therapeutics, Inc.
Annual Revenue Comparison: Halozyme Therapeutics, Inc. vs Perrigo Company plc
Who Generates More Revenue? Halozyme Therapeutics, Inc. or Evotec SE
Who Generates More Revenue? Pharming Group N.V. or BioCryst Pharmaceuticals, Inc.
Who Generates More Revenue? Perrigo Company plc or BioCryst Pharmaceuticals, Inc.
Annual Revenue Comparison: ImmunityBio, Inc. vs BioCryst Pharmaceuticals, Inc.
Breaking Down Revenue Trends: BioCryst Pharmaceuticals, Inc. vs Evotec SE